Mostrando 2 resultados de: 2
HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusPolymeric nanoparticle drug delivery technologies for oral delivery applications
ReviewAbstract: Introduction: Many therapeutics are limited to parenteral administration. Oral administration is a dPalabras claves:chemotherapy, Inflammatory bowel disease, Insulin, M cells, mucoadhesives, mucosal vaccinations, oral delivery, Polymeric nanoparticles, transcytosisAutores:Farokhzad O.C., Frank Alexis, Pridgen E.M.Fuentes:scopus